"Anticonvulsants" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Drugs used to prevent SEIZURES or reduce their severity.
| Descriptor ID |
D000927
|
| MeSH Number(s) |
D27.505.954.427.080
|
| Concept/Terms |
Anticonvulsants- Anticonvulsants
- Anticonvulsive Agents
- Agents, Anticonvulsive
- Anticonvulsive Drugs
- Drugs, Anticonvulsive
- Anticonvulsant Drugs
- Drugs, Anticonvulsant
Antiepileptic Agents- Antiepileptic Agents
- Agents, Antiepileptic
- Antiepileptics
- Antiepileptic Drugs
- Drugs, Antiepileptic
|
Below are MeSH descriptors whose meaning is more general than "Anticonvulsants".
Below are MeSH descriptors whose meaning is more specific than "Anticonvulsants".
This graph shows the total number of publications written about "Anticonvulsants" by people in this website by year, and whether "Anticonvulsants" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 4 | 1 | 5 |
| 1996 | 4 | 2 | 6 |
| 1997 | 2 | 0 | 2 |
| 1998 | 3 | 4 | 7 |
| 1999 | 8 | 3 | 11 |
| 2000 | 5 | 3 | 8 |
| 2001 | 4 | 2 | 6 |
| 2002 | 8 | 0 | 8 |
| 2003 | 14 | 5 | 19 |
| 2004 | 5 | 4 | 9 |
| 2005 | 9 | 2 | 11 |
| 2006 | 10 | 4 | 14 |
| 2007 | 5 | 4 | 9 |
| 2008 | 7 | 1 | 8 |
| 2009 | 9 | 5 | 14 |
| 2010 | 6 | 5 | 11 |
| 2011 | 6 | 4 | 10 |
| 2012 | 6 | 1 | 7 |
| 2013 | 7 | 8 | 15 |
| 2014 | 4 | 3 | 7 |
| 2015 | 11 | 6 | 17 |
| 2016 | 7 | 4 | 11 |
| 2017 | 8 | 1 | 9 |
| 2018 | 10 | 2 | 12 |
| 2019 | 5 | 1 | 6 |
| 2020 | 5 | 3 | 8 |
| 2021 | 5 | 6 | 11 |
| 2022 | 2 | 2 | 4 |
| 2023 | 1 | 5 | 6 |
| 2024 | 7 | 3 | 10 |
| 2025 | 1 | 1 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Anticonvulsants" by people in Profiles.
-
Prescribing errors in hospitalized patients on the ketogenic diet. Am J Health Syst Pharm. 2025 May 23; 82(Supplement_3):S2937-S2942.
-
Ethosuximide-associated Aplastic Anemia Likely Due to Drug-induced Lupus Erythematosus: A Case Report With Immunologic Insights. J Pediatr Hematol Oncol. 2025 Apr 01; 47(3):131-134.
-
An open-label study evaluating the safety and efficacy of AMO-01 for the treatment of seizures in Phelan-McDermid syndrome. HGG Adv. 2025 Apr 10; 6(2):100393.
-
WONOEP appraisal: Targeted therapy development for early onset epilepsies. Epilepsia. 2025 Feb; 66(2):328-340.
-
Antiseizure medication-induced hypersensitivity reactions: Data from a large healthcare system. Seizure. 2024 Nov; 122:172-178.
-
Long-term efficacy and safety of cannabidiol in patients with tuberous sclerosis complex: 3-year results from the cannabidiol expanded access program. Epilepsia Open. 2024 Oct; 9(5):1816-1825.
-
Mechanisms of neurodevelopmental toxicity of topiramate. Crit Rev Toxicol. 2024 Aug; 54(7):465-475.
-
Early Subclinical Status Epilepticus May Contribute to Developmental Delays in Infants With Tuberous Sclerosis Complex. Pediatr Neurol. 2024 Aug; 157:39-41.
-
Familial aggregation of seizure outcomes in four familial epilepsy cohorts. Epilepsia. 2024 Jul; 65(7):2030-2040.
-
Relationship of Neonatal Seizure Burden Before Treatment and Response to Initial Antiseizure Medication. J Pediatr. 2024 May; 268:113957.